2h-1,4-benzoxazine, 3,4-dihydro-2,2-dimethyl-6-nitro-4-(2-pyridinyl)-, n-oxide has been researched along with Disease Models, Animal in 1 studies
*Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. [MeSH]
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brioni, JD; Brune, ME; Coghlan, MJ; Fey, TA; Gopalakrishnan, M; King, LL; Strake, JG; Sullivan, JP | 1 |
1 other study(ies) available for 2h-1,4-benzoxazine, 3,4-dihydro-2,2-dimethyl-6-nitro-4-(2-pyridinyl)-, n-oxide and Disease Models, Animal
Article | Year |
---|---|
Effects of ATP-sensitive K+ channel openers and tolterodine on involuntary bladder contractions in a pig model of partial bladder outlet obstruction.
Topics: Adenosine Triphosphate; Animals; Benzhydryl Compounds; Benzoxazines; Cresols; Cromakalim; Cyclic N-Oxides; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Ion Channel Gating; Muscarinic Antagonists; Muscle Contraction; Oxazines; Parasympatholytics; Phenylpropanolamine; Potassium Channels; Sus scrofa; Tolterodine Tartrate; Urinary Bladder; Urinary Bladder Neck Obstruction; Urodynamics | 2003 |